N/A
Completed N=298
Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients
Fluid Overload
Source: ClinicalTrials.gov NCT02325856 ↗
Enrolled (actual)
298
Serious AEs
0.0%
Results posted
Aug 2015
Primary outcomePrimary: All-cause Hospitalization — 0.52; 0.54 hospitalizations per patient-year
Summary
A reasonable and simple algorithm was used to guide the dry weight determination with Body Composition Monitor with the principle of Bioimpedance Spectroscopy (BCM-BIS) and analyze the feasibility of this algorithm and evaluate the influence of BCM-BIS-guided fluid management on the incidence of dialysis morbidities and clinical outcomes in maintenance hemodialysis (MHD) patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY All-cause Hospitalization |
0.52; 0.54 | — |
| SECONDARY Complications During DW Adjustment |
11.76; 30.88 | — |
Eligibility Criteria
Inclusion Criteria
MHD patients with age ≥ 18 and dialysis vintage ≥ 3 months
Exclusion Criteria
- coronary stents or pacemaker implantation
- metallic devices in body, such as artificial joints or pins
- contralateral or bilateral amputations
- pregnancy
Data sourced from ClinicalTrials.gov (NCT02325856). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.